Next Article in Journal
Establishing the Cost of Implementing a Performance-Based, Managed Entry Agreement for a Hypothetical CAR T-Cell Therapy
Previous Article in Journal
The Potential Price and Access Implications of the Cost-Utility and Budget Impact Methodologies Applied by NICE in England and ICER in the US for a Novel Gene Therapy in Parkinson’s Disease
 
 
Review

No Article Versions Notes Found

Back to TopTop